Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107926295 | 10792629 | 5 | F | 2015 | 20160628 | 20150213 | 20160707 | EXP | PE-PFIZER INC-2015054082 | PFIZER | 54.00 | YR | F | Y | 0.00000 | 20160707 | OT | PE | PE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107926295 | 10792629 | 1 | PS | XALATAN | LATANOPROST | 1 | Ophthalmic | 1 DROP, DAILY IN EACH EYE | 20597 | 1 | GTT | EYE DROPS, SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107926295 | 10792629 | 1 | Glaucoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107926295 | 10792629 | OT |
| 107926295 | 10792629 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107926295 | 10792629 | Acromegaly | |
| 107926295 | 10792629 | Blindness | |
| 107926295 | 10792629 | Blood urine present | |
| 107926295 | 10792629 | Condition aggravated | |
| 107926295 | 10792629 | Growth hormone-producing pituitary tumour | |
| 107926295 | 10792629 | Myopia | |
| 107926295 | 10792629 | Optic nerve compression | |
| 107926295 | 10792629 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107926295 | 10792629 | 1 | 2015 | 0 |